Maito, Nasheed A.

HRN: 27-59-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/03/2025
08/10/2025
IV
21mg
Q24hours
Neonatal Sepsis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  PneumoniaBloodstream    Compliance to guidelines: Compliant To Guidelines